1-4 of 4
Helen L. Lutgers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Arterial Stiffness Is Positively Associated With 18F-fluorodeoxyglucose Positron Emission Tomography–Assessed Subclinical Vascular Inflammation in People With Early Type 2 Diabetes

Stefanie A. de Boer, Marieke C. Hovinga-de Boer, Hiddo J.L. Heerspink, Joop D. Lefrandt, Arie M. van Roon, Helen L. Lutgers, Andor W.J.M. Glaudemans, Pieter W. Kamphuisen, Riemer H.J.A. Slart, Douwe J. Mulder
Journal: Diabetes Care
Diabetes Care 2016;39(8):1440–1447
https://doi.org/10.2337/dc16-0327
Published: 08 June 2016
View article titled, Arterial Stiffness Is Positively Associated With <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography–Assessed Subclinical Vascular Inflammation in People With Early Type 2 Diabetes
Open the PDF for Arterial Stiffness Is Positively Associated With <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography–Assessed Subclinical Vascular Inflammation in People With Early Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Skin Autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications

Esther G. Gerrits, MD, Helen L. Lutgers, MD, Nanne Kleefstra, MD, Reindert Graaff, MSC, PHD, Klaas H. Groenier, PHD, Andries J. Smit, MD, PHD, Rijk O. Gans, MD, PHD, Henk J. Bilo, MD, PHD, FRCP
Journal: Diabetes Care
Diabetes Care 2008;31(3):517–521
https://doi.org/10.2337/dc07-1755
Published: 01 March 2008
View article titled, Skin Autofluorescence: <subtitle>A tool to identify type 2 diabetic patients at risk for developing microvascular complications</subtitle>
Open the PDF for Skin Autofluorescence: <subtitle>A tool to identify type 2 diabetic patients at risk for developing microvascular complications</subtitle> in another window
Journal Articles

Skin Autofluorescence Is a Strong Predictor of Cardiac Mortality in Diabetes

Robbert Meerwaldt, MD, PHD, Helen L. Lutgers, MD, Thera P. Links, MD, PHD, Reindert Graaff, MSC, PHD, John W. Baynes, PHD, Rijk O.B. Gans, MD, PHD, Andries J. Smit, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(1):107–112
https://doi.org/10.2337/dc06-1391
Published: 01 January 2007
View article titled, Skin Autofluorescence Is a Strong Predictor of Cardiac Mortality in Diabetes
Open the PDF for Skin Autofluorescence Is a Strong Predictor of Cardiac Mortality in Diabetes in another window
Journal Articles

Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes

Helen L. Lutgers, MD, Reindert Graaff, MSC, PHD, Thera P. Links, MD, PHD, Lielith J. Ubink-Veltmaat, MD, PHD, Henk J. Bilo, MD, PHD, Rijk O. Gans, MD, PHD, Andries J. Smit, MD, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(12):2654–2659
https://doi.org/10.2337/dc05-2173
Published: 01 December 2006
View article titled, Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes
Open the PDF for Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes in another window